Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Baby Quasar announces the launch of its next-gen skin care tool, Clear Rayz, for the treatment of acne

November 26, 2012

SARASOTA, Fla., Nov. 26, 2012 /PRNewswire/ — The Clear Rayz represents a dramatic advance in acne care. Using both red and blue therapeutic light, the Clear Rayz helps to treat mild to moderate inflammatory acne. The treatment has none of the side effects that plague so many acne medications or topical products. It works on all skin types and ages from teen to adult.

(Photo: http://photos.prnewswire.com/prnh/20121126/FL17758-a)
(Photo: http://photos.prnewswire.com/prnh/20121126/FL17758-b)

Acne is the most common skin disorder. It affects most people at some point in their lives and has a significant impact on self-esteem. Current estimates suggest that consumers spend more than $250 million each year on acne treatments in the U.S. alone.

The Clear Rayz utilizes a patented double sided design that provides acne patients with the maximum light power to achieve the best results. The blue light kills the acne bacteria on the skin. The red light stimulates circulation, healing, and reduces inflammation commonly associated with acne breakouts. It is this combination of benefits that makes the Clear Rayz so unique.

Clear Rayz is classified as a Class II medical device and is cleared for treating mild to moderate inflammatory acne. Clear Rayz utilizes natural, safe, painless, high spectral purity light wavelengths, which are 415 and 660 nanometers. There are no harmful UV rays or irritating chemicals.

About Quasar Bio-Tech Inc.
In 2007, Quasar Bio-Tech redefined skin care and put professional tools in the hands of consumers by introducing revolutionary new home use medical technology, the Baby Quasar. As an industry leader in premium consumer skin care tools, Quasar Bio-Tech continues its commitment to bring the highest quality professional type devices to the market through ongoing research and development. All Quasar Bio-Tech products are made in the USA.

SOURCE Quasar Bio-Tech Inc.


Source: PR Newswire